LCV-56670-61066
1 vaccination
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 190 / PA
- Registered
- 2022-06-28
- Relationship
- Child or adolescent in my care
- Guardian
- XE7-14100-86156
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Pfizer-BioNTech
-
2022-06-28
Registered in v-safe
- 2022-06-28
- 2022-06-29
- 2022-07-07
-
2022-07-14
Survey response — day 21, dose 1, dependentMedDRA: Cough, Headache, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Headache, Runny nose, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Report sent to call center — day 21, dose 1, dependentBe unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-15
Call successfulCompleted over the phone
- 2022-09-22
- 2022-12-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-14 | Successful 2022-07-15 |
Completed over the phone |
Free text
Release 12 — day 21, dose 1, dependent
Symptoms: Headache, Runny nose, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release